Literature DB >> 10624863

Screening of Zulu medicinal plants for angiotensin converting enzyme (ACE) inhibitors.

A C Duncan1, A K Jäger, J van Staden.   

Abstract

Twenty plants used by traditional healers in South Africa for the treatment of high blood pressure were investigated for their anti-hypertensive properties, utilizing the angiotensin converting enzyme assay. A hit rate of 65% was achieved, with the highest inhibition (97%) obtained by Adenopodia spicata leaves. A further seven plants exhibited an inhibition greater than 70% and five more over 50%. The leaves of the plants showed the greatest levels of inhibition. There was little difference in the overall hit rate between ethanolic and aqueous extracts, although in most cases there was a marked difference in activity between aqueous and ethanolic extracts from the same species. Plants exhibiting inhibition levels greater than 50% were further tested for the presence of tannins in order to eliminate possible false positives. Active plants that did not contain tannins were Agapanthus africanus, Agave americana, Clausena anisata, Dietes iridioides, Mesembruanthemum spp., Stangeria eriopus and Tulbaghia violacea.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10624863     DOI: 10.1016/s0378-8741(99)00097-5

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  15 in total

1.  The inhibitory activity of the extracts of popular medicinal herbs on CYP1A2, 2C9, 2C19 and 3A4 and the implications for herb-drug interaction.

Authors:  Pius S Fasinu; Patrick J Bouic; Bernd Rosenkranz
Journal:  Afr J Tradit Complement Altern Med       Date:  2014-06-04

2.  Combination treatment with oxaliplatin and mangiferin causes increased apoptosis and downregulation of NFκB in cancer cell lines.

Authors:  D du Plessis-Stoman; Jgh du Preez; M van de Venter
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-12-30

3.  Antidiabetic and cytotoxicity screening of five medicinal plants used by traditional African health practitioners in the Nelson Mandela Metropole, South Africa.

Authors:  Mea van Huyssteen; Pieter J Milne; Eileen E Campbell; Maryna van de Venter
Journal:  Afr J Tradit Complement Altern Med       Date:  2010-12-30

4.  The ethnomedicine of the Haya people of Bugabo ward, Kagera Region, north western Tanzania.

Authors:  Mainen J Moshi; Donald F Otieno; Pamela K Mbabazi; Anke Weisheit
Journal:  J Ethnobiol Ethnomed       Date:  2009-08-31       Impact factor: 2.733

5.  Antioxidant and acetylcholinesterase-inhibitory properties of long-term stored medicinal plants.

Authors:  Stephen O Amoo; Adeyemi O Aremu; Mack Moyo; Johannes Van Staden
Journal:  BMC Complement Altern Med       Date:  2012-07-07       Impact factor: 3.659

6.  Antibacterial activity of native California medicinal plant extracts isolated from Rhamnus californica and Umbellularia californica.

Authors:  Maria G Carranza; Mary B Sevigny; Debashree Banerjee; Lacie Fox-Cubley
Journal:  Ann Clin Microbiol Antimicrob       Date:  2015-05-23       Impact factor: 3.944

7.  Discovery of new angiotensin converting enzyme (ACE) inhibitors from medicinal plants to treat hypertension using an in vitro assay.

Authors:  Niusha Sharifi; Effat Souri; Seyed Ali Ziai; Gholamreza Amin; Massoud Amanlou
Journal:  Daru       Date:  2013-12-20       Impact factor: 3.117

8.  Bioactivity-Guided Fractionation of Pine Needle Reveals Catechin as an Anti-hypertension Agent via Inhibiting Angiotensin-Converting Enzyme.

Authors:  Jian He
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

Review 9.  Review of Angiotensin-converting Enzyme Inhibitory Assay: Rapid Method in Drug Discovery of Herbal Plants.

Authors:  Islamudin Ahmad; Arry Yanuar; Kamarza Mulia; Abdul Mun'im
Journal:  Pharmacogn Rev       Date:  2017 Jan-Jun

10.  Traditional medicine practices among community members with diabetes mellitus in Northern Tanzania: an ethnomedical survey.

Authors:  Joseph Lunyera; Daphne Wang; Venance Maro; Francis Karia; David Boyd; Justin Omolo; Uptal D Patel; John W Stanifer
Journal:  BMC Complement Altern Med       Date:  2016-08-11       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.